Effects of 2-year treatment with calcitonin in postmenopausal osteoporosis

被引：0
|
作者：
Gurer, G. [1 ]
Sendur, O. F. [1 ]
Tastaban, E. [1 ]
Aydemir, A. H. [1 ]
机构：
[1] Adnan Menderes Univ, Fac Med, Dept Phys Med & Rehabil, Aydin, Turkey
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S261 / S261
页数：1
相关论文
共 50 条
  • [1] Effects of 2-year treatment with risedronate in postmenopausal osteoporosis
    Sendur, O. F.
    Gurer, G.
    Aydemir, A. H.
    Tastaban, E.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S267 - S268
  • [2] Alendronate vs. calcitonin: 2-year treatment of osteoporosis in postmenopausal women
    Rosen, CJ
    Schnitzer, TJ
    McClung, M
    Miller, PD
    Wang, L
    Vanaman, LK
    Yates, J
    Melton, ME
    Palmisano, J
    BONE, 2001, 28 (05) : S226 - S226
  • [3] Effects of a standardized Osteoporosis-Training in postmenopausal Osteoporosis - a 2-year Prospective Study
    Lange, U.
    Tarner, I.
    Mueller-Ladner, U.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 97 - 97
  • [4] Alendronate vs intranasal calcitonin for treatment of osteoporosis in postmenopausal women: 2 Year results
    Downs, RW
    Bell, NH
    Walsh, B
    Ettinger, MP
    Mako, B
    Smith, ME
    Wang, L
    Yates, J
    Melton, ME
    Palmisano, J
    BONE, 2001, 28 (05) : S229 - S229
  • [5] CALCITONIN FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    BODY, JJ
    CLINICAL RHEUMATOLOGY, 1995, 14 : 18 - 21
  • [6] POSTMENOPAUSAL OSTEOPOROSIS - PREVENTION AND TREATMENT WITH CALCITONIN
    PRELEVIC, GM
    ADASHI, EY
    GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (02) : 141 - 147
  • [7] Comparison of the effects of alendronate, risedronate and calcitonin treatment in postmenopausal osteoporosis
    Yildirim, K
    Gureser, G
    Karatay, S
    Melikoglu, MA
    Ugur, M
    Erdal, A
    Senel, K
    Billen, H
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2005, 18 (3-4) : 85 - 89
  • [8] A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data
    Michael R. McClung
    Claude-Laurent Benhamou
    Zulema Man
    Witold Tlustochowicz
    Jose R. Zanchetta
    Rachelle Eusebio
    Ana M. Balske
    Ellen Matzkin
    Wojciech P. Olszynski
    Robert Recker
    Pierre D. Delmas
    Calcified Tissue International, 2013, 92 : 59 - 67
  • [9] A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data
    McClung, Michael R.
    Benhamou, Claude-Laurent
    Man, Zulema
    Tlustochowicz, Witold
    Zanchetta, Jose R.
    Eusebio, Rachelle
    Balske, Ana M.
    Matzkin, Ellen
    Olszynski, Wojciech P.
    Recker, Robert
    Delmas, Pierre D.
    CALCIFIED TISSUE INTERNATIONAL, 2013, 92 (01) : 59 - 67
  • [10] Comparison of the effects of teriparatide and calcitonin in the treatment of postmenopausal Chinese women with osteoporosis
    Blair, J. M.
    Dai, K. R.
    Chen, D. C.
    Zhang, Z. L.
    Zhang, K. Q.
    Wang, B. Q.
    He, L.
    Liu, B.
    Xu, H. Z.
    Hu, Y. L.
    Cao, Y. P.
    Thiebaud, D.
    Yu, M.
    Luo, T. H.
    BONE, 2009, 44 : S74 - S74
12345